TheProfitWatch

GLUE - Monte Rosa Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
13.45 0.85 (6.32%) -0.02 (-0.17%) -0.02 (-0.17%) -0.04 (-0.28%) 0.0 (0.0%) 0.85 (6.32%) --- 0.0 (0.0%)

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
50.0
VWAP:
14.31
RVol:

Events

Period Kind Movement Occurred At

Related News